Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead (also styled GILEAD), is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Gilead Sciences is implementing good security practices.
Read more about the latest issues in cybersecurity
Formulating an IT security risk assessment methodology is a key part of building a robust ...
NIST Special Publication 800-171, Protecting Controlled Unclassified Information in Nonfederal ...
Compare Gilead Sciences's security performance with other companies